2. Signaling Pathways
  3. Membrane Transporter/Ion Channel
  4. Sodium Channel
  5. Sodium Channel Control

Sodium Channel Control

Sodium Channel Isoform Comparison

Sodium Channel Controls (4):

Cat. No. Product Name Effect Purity
  • HY-114937
    (R)-Eslicarbazepine acetate
    		Control
    (R)-Eslicarbazepine acetate (BIA 2-059) is the R-enantiomer of Eslicarbazepine acetate (HY-B0703). Eslicarbazepine acetate is an antiepileptic agent, is a dual a dual Inhibitor of β-Secretase and voltage-gated sodium channel.
  • HY-107370A
    (Rac)-Atomoxetine hydrochloride
    		Control
    (Rac)-Atomoxetine hydrochloride ((Rac)-Tomoxetine (hydrochloride); (Rac)-LY 139603) is the racemic mixture of Atomoxetine hydrochloride (HY-17385). Atomoxetine hydrochloride is a selective noradrenaline reuptake inhibitor with Ki values of 5, 77 and 1451 nM for norepinephrine (NE), serotonin (5-HT) and dopamine (DA) transporters, respectively. Atomoxetine hydrochloride increases of DAEX and NEEX in the PFC and enhances catecholaminergic neurotransmission. Atomoxetine hydrochloride is a potent Na+ channels (VGSCs) blocker. Atomoxetine hydrochloride can be used for attention-deficit hyperactivity disorder (ADHD) research.
  • HY-156054
    N-Hydroxy riluzole
    		Control
    N-Hydroxy riluzole is a metabolite of the antiglutamatergic agent Riluzole (HY-B0211).
  • HY-W653803
    Lamotrigine N2-Oxide
    		Control
    Lamotrigine N2-Oxide is a metabolite of the anticonvulsant Lamotrigine (HY-B0495).